Lorlatinib
Lorlatinib | |
---|---|
Term | Lorlatinib |
Short definition | Lorlatinib (lor-LA-tih-quill) A drug used to treat adults with non-small cell lung cancer that has spread to other parts of the body and is ALK-positive. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Lorlatinib - (pronounced) (lor-LA-tih-quill) A drug used to treat adults with non-small cell lung cancer that has spread to other parts of the body and is ALK-positive. It is also being studied in the treatment of other types of cancer. Lorlatinib blocks certain proteins made by the ALKGene. Blocking these proteins can stop cancer cells from growing and spreading. Lorlatinib is a type of tyrosine kinase inhibitor. Also called Lorbrena
External links
- Medical encyclopedia article on Lorlatinib
- Wikipedia's article - Lorlatinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski